A Klotho-based Machine Learning Model for Prediction of both Kidney and Cardiovascular Outcomes in Chronic Kidney Disease

Background: This study aimed to develop and validate a machine learning (ML) model based on serum Klotho for predicting end-stage kidney disease (ESKD) and cardiovascular disease (CVD) in patients with chronic kidney disease (CKD). Methods: Five different ML models were trained to predict the risk o...

Full description

Bibliographic Details
Main Authors: Yating Wang, Yu Shi, Tangli Xiao, Xianjin Bi, Qingyu Huo, Shaobo Wang, Jiachuan Xiong, Jinghong Zhao
Format: Article
Language:English
Published: Karger Publishers 2024-03-01
Series:Kidney Diseases
Online Access:https://beta.karger.com/Article/FullText/538510
_version_ 1797201811217580032
author Yating Wang
Yu Shi
Tangli Xiao
Xianjin Bi
Qingyu Huo
Shaobo Wang
Jiachuan Xiong
Jinghong Zhao
author_facet Yating Wang
Yu Shi
Tangli Xiao
Xianjin Bi
Qingyu Huo
Shaobo Wang
Jiachuan Xiong
Jinghong Zhao
author_sort Yating Wang
collection DOAJ
description Background: This study aimed to develop and validate a machine learning (ML) model based on serum Klotho for predicting end-stage kidney disease (ESKD) and cardiovascular disease (CVD) in patients with chronic kidney disease (CKD). Methods: Five different ML models were trained to predict the risk of ESKD and CVD at three different time points (3, 5, and 8-year) using a cohort of 400 non-dialysis CKD patients. The dataset was divided into a training set (70%) and an internal validation set (30%). These models were informed by data comprising 47 clinical features, including serum Klotho. The best-performing model was selected and used to identify risk factors for each outcome. Model performance was assessed using various metrics. Results: The findings showed that the Lasso regression model had the highest accuracy (C-index=0.71) in predicting ESKD. The features mainly included in this model were estimated glomerular filtration rate (eGFR), 24-hour urinary microalbumin, serum albumin, phosphate, parathyroid hormone, and serum Klotho, which achieved the highest area under the curve (AUC) of 0.930 (95% CI: 0.897-0.962). In addition, for the CVD risk prediction, the Random Survival Forest (RSF) model with the highest accuracy (C-index=0.66) was selected and achieved the highest AUC of 0.782 (95% CI: 0.633-0.930). The features mainly included in this model were age, history of primary hypertension, calcium, tumor necrosis factor-alpha, and serum Klotho. Conclusion: We successfully developed and validated Klotho-based ML risk prediction models for CVD and ESKD in CKD patients with good performance, indicating their high clinical utility.
first_indexed 2024-04-24T07:53:28Z
format Article
id doaj.art-934f529a88cf409ca3682e2957302dcd
institution Directory Open Access Journal
issn 2296-9357
language English
last_indexed 2024-04-24T07:53:28Z
publishDate 2024-03-01
publisher Karger Publishers
record_format Article
series Kidney Diseases
spelling doaj.art-934f529a88cf409ca3682e2957302dcd2024-04-18T07:17:49ZengKarger PublishersKidney Diseases2296-93572024-03-011110.1159/000538510538510A Klotho-based Machine Learning Model for Prediction of both Kidney and Cardiovascular Outcomes in Chronic Kidney DiseaseYating WangYu ShiTangli XiaoXianjin BiQingyu HuoShaobo WangJiachuan XiongJinghong ZhaoBackground: This study aimed to develop and validate a machine learning (ML) model based on serum Klotho for predicting end-stage kidney disease (ESKD) and cardiovascular disease (CVD) in patients with chronic kidney disease (CKD). Methods: Five different ML models were trained to predict the risk of ESKD and CVD at three different time points (3, 5, and 8-year) using a cohort of 400 non-dialysis CKD patients. The dataset was divided into a training set (70%) and an internal validation set (30%). These models were informed by data comprising 47 clinical features, including serum Klotho. The best-performing model was selected and used to identify risk factors for each outcome. Model performance was assessed using various metrics. Results: The findings showed that the Lasso regression model had the highest accuracy (C-index=0.71) in predicting ESKD. The features mainly included in this model were estimated glomerular filtration rate (eGFR), 24-hour urinary microalbumin, serum albumin, phosphate, parathyroid hormone, and serum Klotho, which achieved the highest area under the curve (AUC) of 0.930 (95% CI: 0.897-0.962). In addition, for the CVD risk prediction, the Random Survival Forest (RSF) model with the highest accuracy (C-index=0.66) was selected and achieved the highest AUC of 0.782 (95% CI: 0.633-0.930). The features mainly included in this model were age, history of primary hypertension, calcium, tumor necrosis factor-alpha, and serum Klotho. Conclusion: We successfully developed and validated Klotho-based ML risk prediction models for CVD and ESKD in CKD patients with good performance, indicating their high clinical utility.https://beta.karger.com/Article/FullText/538510
spellingShingle Yating Wang
Yu Shi
Tangli Xiao
Xianjin Bi
Qingyu Huo
Shaobo Wang
Jiachuan Xiong
Jinghong Zhao
A Klotho-based Machine Learning Model for Prediction of both Kidney and Cardiovascular Outcomes in Chronic Kidney Disease
Kidney Diseases
title A Klotho-based Machine Learning Model for Prediction of both Kidney and Cardiovascular Outcomes in Chronic Kidney Disease
title_full A Klotho-based Machine Learning Model for Prediction of both Kidney and Cardiovascular Outcomes in Chronic Kidney Disease
title_fullStr A Klotho-based Machine Learning Model for Prediction of both Kidney and Cardiovascular Outcomes in Chronic Kidney Disease
title_full_unstemmed A Klotho-based Machine Learning Model for Prediction of both Kidney and Cardiovascular Outcomes in Chronic Kidney Disease
title_short A Klotho-based Machine Learning Model for Prediction of both Kidney and Cardiovascular Outcomes in Chronic Kidney Disease
title_sort klotho based machine learning model for prediction of both kidney and cardiovascular outcomes in chronic kidney disease
url https://beta.karger.com/Article/FullText/538510
work_keys_str_mv AT yatingwang aklothobasedmachinelearningmodelforpredictionofbothkidneyandcardiovascularoutcomesinchronickidneydisease
AT yushi aklothobasedmachinelearningmodelforpredictionofbothkidneyandcardiovascularoutcomesinchronickidneydisease
AT tanglixiao aklothobasedmachinelearningmodelforpredictionofbothkidneyandcardiovascularoutcomesinchronickidneydisease
AT xianjinbi aklothobasedmachinelearningmodelforpredictionofbothkidneyandcardiovascularoutcomesinchronickidneydisease
AT qingyuhuo aklothobasedmachinelearningmodelforpredictionofbothkidneyandcardiovascularoutcomesinchronickidneydisease
AT shaobowang aklothobasedmachinelearningmodelforpredictionofbothkidneyandcardiovascularoutcomesinchronickidneydisease
AT jiachuanxiong aklothobasedmachinelearningmodelforpredictionofbothkidneyandcardiovascularoutcomesinchronickidneydisease
AT jinghongzhao aklothobasedmachinelearningmodelforpredictionofbothkidneyandcardiovascularoutcomesinchronickidneydisease
AT yatingwang klothobasedmachinelearningmodelforpredictionofbothkidneyandcardiovascularoutcomesinchronickidneydisease
AT yushi klothobasedmachinelearningmodelforpredictionofbothkidneyandcardiovascularoutcomesinchronickidneydisease
AT tanglixiao klothobasedmachinelearningmodelforpredictionofbothkidneyandcardiovascularoutcomesinchronickidneydisease
AT xianjinbi klothobasedmachinelearningmodelforpredictionofbothkidneyandcardiovascularoutcomesinchronickidneydisease
AT qingyuhuo klothobasedmachinelearningmodelforpredictionofbothkidneyandcardiovascularoutcomesinchronickidneydisease
AT shaobowang klothobasedmachinelearningmodelforpredictionofbothkidneyandcardiovascularoutcomesinchronickidneydisease
AT jiachuanxiong klothobasedmachinelearningmodelforpredictionofbothkidneyandcardiovascularoutcomesinchronickidneydisease
AT jinghongzhao klothobasedmachinelearningmodelforpredictionofbothkidneyandcardiovascularoutcomesinchronickidneydisease